|Organic compounds -- part of the class 532-570 series patents - Monitor Patents|
USPTO Class 536 | Browse by Industry: Previous - Next | All
07/2010 | Recent | 13: May | Apr | Mar | Feb | Jan | 12: Dec | Nov | Oct | Sep | Aug | July | June | May | April | Mar | Feb | Jan | 11: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan | 10: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan | | 09: Dec | Nov | Oct | Sep | Aug | Jl | Jn | May | Apr | Mar | Fb | Jn | | 2008 | 2007 |
Organic compounds -- part of the class 532-570 series July category listing 07/10Below are recently published patent applications awaiting approval from the USPTO. Recent week's RSS XML file available below.
Listing for abstract view: USPTO application #, Title, Abstract excerpt,Patent Agent. Listing format for list view: USPTO National Class full category number, title of the patent application. 07/29/2010 > patent applications in patent subcategories. category listing
20100190968 - Oleanane triterpene saponin compounds which are effective on treatment of dementia and mild cognitive impairment (mci) and improvement of cognitive function: The present invention relates to the use of oleanane-type triterpene saponin compounds, which are effective for improving memory and learning ability, as an effective ingredient of drugs for the treatment and prevention of dementia and mild cognitive impairment and health foods for the improvement of brain functions including cognitive function.... Agent: Frommer Lawrence & Haug
20100190969 - Non-naturally occurring carbohydrate-based fibrous elements and methods for making same: Non-naturally occurring carbohydrate-based fibrous elements and more particularly, non-naturally occurring carbohydrate-based fibrous elements having a macrostructure and a microstructure wherein the microstructure is visible when wet and methods for making same are provided.... Agent: The Procter & Gamble Company Global Legal Department - Ip
20100190970 - Genetic lesion associated with cancer: The invention comprises methods for identifying mutations within the 3′ UTRs of genes that lead to increased risk or probability of developing cancer.... Agent: Mintz Levin Cohn Ferris Glovsky And Popeo, P.C.
20100190971 - Sirna targeting diacylglycerol o-acyltransferase homolog 2 (dgat2): Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed... Agent: Kalow & Springut LLP
20100190972 - Heteropolynucleotide duplexes with purine-purine base pairing: The present invention relates to stable anti-parallel heteropolynucleotide duplexes, comprising a plurality of complementary purine-purine nucleobase dyads, wherein the nucleobase is coupled to a pentose sugar backbone. The present invention further relates to methods of hybridizing two heteropolynucleotide molecules to form such purine-purine nucleobase dyads, as well as kits and... Agent: Siemens Corporation Intellectual Property Department
20100190973 - Single step process for separating biomass components: The invention is directed towards a method of pretreatment of a lignocellulose containing biomass so as to make the biomass amenable to enzymatic digestion. More particularly, the instant application discloses a single step separation of biomass into individual components such as cellulose, hemicellulose and lignin without losing chemical nature and... Agent: Edwards Angell Palmer & Dodge LLP
20100190974 - Solid phase reaction method and apparatus: A solid phase reaction method comprising an elongate material of (1) with a substance provided thereon through at least one reaction zone (2) and comprises at least one group for attachment to at least one linker species of said substance. The elongate material (1) may be a cord ribbon, thread... Agent: Morgan, Lewis & Bockius LLP (sf)
20100190975 - Method for purification of chlorinated sucrose derivatives by solvent extraction: A process is described for extractive isolation and purification of Trichlorogalactosucrose from impurities from a composition substantially free from N-N Dimethylformamide (DMF) comprising a first extractive separation by adjusting aqueous to a mixture of organic solvents in the composition to a certain ratio of aqueous to organic phase, extracting the... Agent: The Nath Law Group
20100190976 - Novel process for the recovery of beta acetylfuranoside: There is provided an improved method for the recovery of residual, unseparated β-ACF from reaction mixtures remaining from an initial synthesis of ACF, which is in particular usable on a large industrial scale, more particularly in the production of capecitabine.... Agent: Hoffmann-la Roche Inc. Patent Law Department07/22/2010 > patent applications in patent subcategories. category listing
20100184965 - Complex consisted of a polysaccharide and an hbp: The invention relates to a complex consisted of a polysaccharide and an HBP, said polysaccharide being consisted from glycoside bonds of (1,6) and/or (1,4) and/or (1,3) and/or (1,2) type and functionalized with at least one salifiable or salified tryptophan derivative. The invention also relates to a pharmaceutical composition comprising a... Agent: Oliff & Berridge, PLC
20100184966 - 5'-modified bicyclic nucleic acid analogs: The present invention provides 5′-modified bicyclic nucleoside analogs and oligomeric compounds comprising at least one of these nucleoside analogs. In preferred embodiments the nucleoside analogs have either (R) or (S)-chirality at the 5′-carbon. These bicyclic nucleoside analogs are useful for enhancing properties of oligomeric compounds including for example enhanced nuclease... Agent: Jones Day For Isis Pharmaceuticals, Inc.
20100184967 - Biomarkers for inflammatory bowel disease and irritable bowel syndrome: The present invention provides compositions and their use in diagnosing and/or distinguishing inflammatory bowel disease and irritable bowel syndrome.... Agent: Mcdonnell Boehnen Hulbert & Berghoff LLP
20100184968 - Method for preparing an oxidised cellulose compress: A method for preparing an oxidized cellulose complex essentially comprises oxidizing the compress with a hypohalite, in the presence of an oxoammonium salt... Agent: Heslin Rothenberg Farley & Mesiti PC
20100184969 - Process to prepare sucralose: The present invention relates to a process to prepare sucralose. More particularly the said process relates to the production of sucralose, chemically known as, 6-Dichloro-1,6-dideoxy-β-D-fructofuranosyl-4-chloro-4-deoxy-alpha-D-galactopyranoside of formula (1)... Agent: Ladas & Parry LLP07/15/2010 > patent applications in patent subcategories. category listing
20100179309 - Modified irna agents: The invention relates to iRNA agents, which preferably include a monomer in which the ribose moiety has been replaced by a moiety other than ribose. The inclusion of such a monomer can allow for modulation of a property of the iRNA agent into which it is incorporated, e.g., by using... Agent: Nixon Peabody LLP
20100179310 - Genetic analysis of cells: Some aspects relate to methods for genetic analysis of selected cells from within a heterogeneous population of cells. The population of cells first can be partitioned. Selected cells are identified by imaging, and then specifically targeted and lysed by irradiation with an energy beam, resulting in specific release of their... Agent: Knobbe Martens Olson & Bear LLP
20100179311 - Reactions of group 16 elements: Reactions of Group 16 elements involving the addition of atoms such as sulfur, selenium or tellurium to organic or inorganic molecules comprising use of an ionic liquid as a reaction medium.... Agent: Carstens & Cahoon, LLP
20100179312 - Convertible nucleoside derivatives: The present invention is directed to convertible nucleosides and polymer supported convertible nucleosides for use in SNAP displacement reactions. The convertible nucleosides can be used to synthesize numerous substituted purine and pyrimidine derivatives.... Agent: Hoffmann & Baron, LLP
20100179313 - Process for preparing an a2a-adenosine receptor agonist and its polymorphs: Disclosed is a synthesis suitable for large scale manufacture of an A2A-adenosine receptor agonist, and also relates to polymorphs of that compound, and to methods of isolating a specific polymorph.... Agent: Swiss Tanner, P.C. P.o. Box 1749
20100179314 - Novel and highly stereoselective process for preparing gemcitabine and intermediates thereof: The present invention provides a novel and highly stereoselective process for preparing gemcitabine, which is suitable for industrial production, wherein, it includes the following reactions. Additionally, the invention discloses the key intermediates. The definition for the groups of G1, G2, G3, G4, and G5 are described in the specification.... Agent: Kolisch Hartwell, P.C.
20100179315 - Processing biomass: Biomass (e.g., plant biomass, animal biomass, and municipal waste biomass) is processed to produce useful products, such as fuels. For example, systems can use feedstock materials, such as cellulosic and/or lignocellulosic materials and/or starchy or sugary materials, to produce ethanol and/or butanol, e.g., by fermentation.... Agent: Xyleco, Inc. Celia Leber07/08/2010 > patent applications in patent subcategories. category listing
20100174055 - Assay for bcr/abl gene rearrangement: The present invention provides a simple high-throughput assay for detecting bcr/abl translocations. The method includes qualitative PCR methods for identifying the particular amplified translocation (e1a2 or b2a3/b3a2) and real time PCR for quantifying an amount of bcr/abl transcript (e1a2, b2a3 and b3a2). Quantitative measurement of ber/abl transcript in accordance with... Agent: Foley & Lardner LLP
20100174056 - Recombinant tumor specific antibody and use thereof: The invention provides a family of antibodies that specifically bind the human epithelial cell adhesion molecule. The antibodies comprise modified variable regions, more specially, modified framework regions, which reduce their immunogenicity when administered to a human. The antibodies, when coupled to the appropriate moiety, may be used in the diagnosis,... Agent: Goodwin Procter LLP Patent Administrator
20100174057 - Dengue serotype 2 attenuated strain: The invention relates to live attenuated VDV2 (VERO-Derived Vaccine Dengue serotype 2) strains which have been derived from the wild-type dengue-2 strain 16681 by passaging on PDK and Vero cells and nucleic acids thereof. The invention further relates to a vaccine composition which comprises a VDV2 strain.... Agent: Stites & Harbison PLLC
20100174058 - Fluorescent quenching detecting reagents and methods: Oligonucleotide probes containing two labels are provided and are useful in hybridization assays. The probes can also contain a minor groove binding group.... Agent: Jackson Walker LLP
20100174059 - Process for the production of nucleotide sugars: The current invention provides methods (e.g., large-scale processes) for the production of nucleotide sugars, which are modified with a polymeric modifying group, such as poly(alkylene oxide) moieties (e.g., poly(ethylene glycol) or poly(propylene glycol)) moieties. A typical process of the invention includes anion exchange chromatography followed by an ultrafiltration procedure, such... Agent: Leydig Voit & Mayer, Ltd
20100174060 - Lyocell fiber for tire cord and tire cord comprising the same: The present invention relates to a lyocell fiber having superior the crystalline properties, which are measured by wet-treated and dry-treated condition under high temperature and high pressure conditions compared to measurement under standard conditions, and to a tire cord comprising the lyocell fiber. According to the present invention, the lyocell... Agent: Sughrue Mion, PLLC
20100174061 - Plants which synthesize a modified starch, process for the production thereof and modified starch: Nucleic acid molecules are described encoding a starch granule-bound protein as well as methods and recombinant DNA molecules for the production of transgenic plant cells and plants synthesizing a modified starch with modified viscosity properties and a modified phosphate content. Moreover, the plant cells and plants resulting from those methods... Agent: Oblon, Spivak, Mcclelland Maier & Neustadt, L.L.P.
20100174062 - Modified xanthan gum, modified gum arabic, and modified tamarind seed gum, and methods for crosslinking xanthan gum, gum arabic, and tamarind seed gum: In one aspect, the invention is a modified xanthan gum produced by crosslinking xanthan gum by irradiating a solution containing 10 to 70% by weight of xanthan gum with 5 to 200 kGy of radiation. In another aspect, the invention is a modified gum arabic produced by crosslinking gum arabic... Agent: Trexler, Bushnell, Giangiorgi, Blackstone & Marr, Ltd.
20100174063 - Polysaccharide produced by microorganism belonging to genus bifidobacterium: A polysaccharide comprising galactose, glucose, rhamnose, and pyruvic acid as constituents, wherein the galactose, glucose, and rhamnose are contained in a molar ratio of 4:2:1, and the pyruvic acid is contained in an amount of 4 to 7 wt %. The polysaccharide can be obtained by culturing Bifidobacterium longum JBL05... Agent: Renner Otto Boisselle & Sklar, LLP07/01/2010 > patent applications in patent subcategories. category listing
20100168405 - Activator including biosurfactant as active ingredient, mannosyl erythritol lipid, and production method thereof: The present invention includes as an active ingredient at least one biosurfactant, in particular mannosyl alditol lipid (such as MEL and MML) or triacylated mannosyl alditol lipid. This allows providing an activator and anti-aging agent that is excellent in activating and anti-aging effects on cells and that is safe enough... Agent: Fish & Richardson P.C.
20100168406 - Use of ginsenoside rb2 monomer in the manufacture of medicaments for thrombolysis: The present invention discloses use of ginsenoside Rb2 in the manufacture of drugs. Said drugs not only can dissolve thrombi and protect against reperfusion injury, but also can improve microcirculation, help to repair the injured tissues and cells, improve local or even systemic physiological conditions. Additional advantages include reduced bleeding... Agent: Ladas & Parry LLP
20100168407 - Quaternized carboxymethyl chitosan derivatives and preparation method thereof: The invention relates to a novel kind of chitosan derivative, specifically to quaternized carboxymethyl chitosand derivatives and preparation method. Chitosan with different molecular weight reacts with chloroactic acid give rise to carboxymethyl chitosan. After reaction of Schiff based, deoxidized and quaternized, quaternized carboxymethyl chitosan is obtained. This kind of chitosan... Agent: Smith, Gambrell & Russell
20100168408 - Compositions and methods for labeling of nucleic acid molecules: The present invention is generally related to compositions, kits and methods for labeling nucleic acid molecules using reverse transcriptases, preferably multi-subunit reverse transcriptases such as ASLV reverse transcriptases. Specifically, the invention relates to methods, kits and compositions for to fluorescently labeling nucleic acid molecules during nucleic acid synthesis. The labeled... Agent: Life Technologies Corporation C/o Intellevate
20100168409 - Thermoplastic resin film and method for producing same: To provide a thermoplastic resin film, and process for producing the same, which can obtain a film having high optical properties in which the occurrence of residual strain and the exhibition of retardation during film forming are suppressed. A film (12) is produced by extruding melted thermoplastic resins in sheet... Agent: Sughrue Mion, PLLC
20100168410 - Hydroxypropyl methyl cellulose hard capsules and process of manufacture: A composition for manufacture of hard hydroxypropyl methyl cellulose capsules comprising a film forming material of hydroxypropyl methyl cellulose having a methoxy content of 27.0-30.0% (w/w), and a hydroxypropoxy content of 4.0-7.5% and as a 2% weight solution, a viscosity of 3.5-6.0 cPs at 20° C., dipping compositions, process for... Agent: Pfizer Inc. Patent Department
20100168411 - Method of producing fermentation product and fermentation product: Provided are a fermentation product, which shows a strong antioxidative effect and is efficacious against diseases caused by active oxygen, and a method of producing the same. Stems and leaves of a perennial gramineous plant (rice straw, reed, barely straw, etc.) are mixed with a fermentation medium which comprises egg... Agent: Lee Fredric Sharra
20100168412 - Continuous neutralizer mixer reactor and a continuous process for quenching chlorination reaction mixture in production of chlorinated sucrose: An improved process of production of a chlorinated sugar is described comprising chlorination of a partially protected sugar, wherein quenching as well as neutralization of chlorinated reaction mass is carried out concurrently and continuously in a reactor which is a continuous mixer as well as quencher providing continuous mixing of... Agent: The Nath Law GroupPrevious industry: Organic compounds -- part of the class 532-570 series
Next industry: Organic compounds -- part of the class 532-570 series
RSS FEED for 20130516:
Integrate FreshPatents.com into your RSS reader/aggregator or website to track weekly updates.
For more info, read this article.
Thank you for viewing Organic compounds -- part of the class 532-570 series patents on the FreshPatents.com website. These are patent applications which have been filed in the United States. There are a variety ways to browse Organic compounds -- part of the class 532-570 series patent applications on our website including browsing by date, agent, inventor, and industry. If you are interested in receiving occasional emails regarding Organic compounds -- part of the class 532-570 series patents we recommend signing up for free keyword monitoring by email.
FreshPatents.com Support - Terms & Conditions
Results in 0.39803 seconds